AXL inhibition in tumor cells decreases the secretion of pro-angiogenic factors such as endothelin and VEGF-A and impairs functional properties of endothelial cells in vivo, suggesting its important role in the initiation of tumor angiogenesis (Tanaka and Siemann, 2019). This evidence concerns the gene VEGFA and neoplasm.